Validation of the RBD Symptom Severity Scale in the North American Prodromal Synucleinopathy Consortium.
Parichita ChaudhuryJoyce K Lee-IannottiAndrea O BusicescuPooja RanganMaria Livia FantiniAlon Y AvidanDonald L BliwiseSusan R CriswellEmmanuel H DuringJonathan E ElliottJulie A FieldsJean-François GagnonMichael J HowellDaniel E HuddlestonJennifer McLelandEmmanuel Jean-Marie MignotMitchell G MiglisMiranda M LimAmélie PelletierCarlos H SchenckDavid R ShprecherErik K St LouisAleksandar VidenovicYo-El S JuBradley F BoeveRonald B Postumanull nullPublished in: Neurology (2024)
We describe the RBDSSS with adequate psychometric and clinimetric properties to quantify RBD symptom severity and good concordance between participant and bedpartner questionnaires and between RBDSSS scores and clinician-assessed global severity.